CLINICAL_TRIALS ClinicalTrials.gov record update

Evaluation of the Benefits and Risks in Maintenance Renal Transplant Recipients Following Conversion to Nulojix® (Belatacept)-Based Immunosuppression

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01820572
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:52.478292+00:00
Published At: 2021-01-05T00:00:00+00:00
Record Updated At: 2021-01-05
Results Posted At: 2021-01-05
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Kidney Transplantation"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2021-01-05"
protocolSection.identificationModule.nctId: "NCT01820572"
protocolSection.identificationModule.officialTitle: "Evaluation of the Benefits and Risks in Maintenance Renal Transplant Recipients Following Conversion to Nulojix\u00ae (Belatacept)-Based Immunosuppression"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2021-01-05"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.